These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 10524079)

  • 1. [GP11b/111a receptor antagonists. Better prognoses in acute coronary syndromes].
    Krankenpfl J; 1999 May; 37(5):180-1. PubMed ID: 10524079
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycoprotein IIb-IIIa antagonists in percutaneous coronary interventions and acute coronary syndromes.
    Ramanathan A; Kleiman NS
    Indian Heart J; 1998 Oct; 50 Suppl 1():45-56. PubMed ID: 9824907
    [No Abstract]   [Full Text] [Related]  

  • 3. Basic and clinical aspects of platelet integrin alphaIIbbeta3 receptor antagonists in acute coronary syndromes.
    Goudevenos JA; Tselepis AD
    Curr Opin Investig Drugs; 2001 Feb; 2(2):244-9. PubMed ID: 11816838
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
    Galli M; Maggioni AP; Vassanelli C; Tavazzi L
    Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in antiplatelet therapy for acute coronary syndromes.
    Clem JR; Falls S
    S D J Med; 1998 Jul; 51(7):233-4. PubMed ID: 9676157
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?
    Maree A; Fitzgerald DJ
    Semin Vasc Med; 2003 Nov; 3(4):385-90. PubMed ID: 15199445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes.
    Van de Werf F
    Thromb Haemost; 1997 Jul; 78(1):210-3. PubMed ID: 9198155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of patients with acute coronary syndrome in the United States with glycoprotein IIb/IIIa inhibitors. Data provided by the PURSUIT study].
    Galvani M
    Ital Heart J Suppl; 2000 Dec; 1(12):1650-1. PubMed ID: 11221597
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
    Maree A; Fitzgerald D
    Haematologica; 2001 Nov; 86(11 Suppl 2):45-8. PubMed ID: 11926777
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibitors of GPIIb/IIIa platelet receptors].
    Chanu B
    Arch Mal Coeur Vaiss; 1999 Jul; 92(7):893-902. PubMed ID: 10443310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glycoprotein IIB/IIIA receptor blockers as treatment of acute coronary syndromes and interventional cardiology].
    Abramovitch N; Halon DA; Flugelman Y; Lewis BS
    Harefuah; 1998 Jul; 135(1-2):41-7. PubMed ID: 10909532
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Landolfi R; De Cristofaro R
    Lancet; 2002 Jul; 360(9328):257. PubMed ID: 12133682
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Meier JJ; Gallwitz B; Schmidt WE; Nauck MA
    Lancet; 2002 Jul; 360(9328):257. PubMed ID: 12133683
    [No Abstract]   [Full Text] [Related]  

  • 14. [Eptifibatide in acute coronary syndromes. Comments on the practice guidelines in antithrombotic treatment].
    Díaz de Rojas F; Ponte A; Cuenllas E
    Rev Esp Cardiol; 2000 Feb; 53(2):302-3. PubMed ID: 10734766
    [No Abstract]   [Full Text] [Related]  

  • 15. [Safety and economic efficiency of platelet IIb/IIIa receptor blockers in acute coronary syndromes without ST-segment elevation].
    Latour-Pérez J
    Rev Esp Cardiol; 2000 Aug; 53(8):1148-50. PubMed ID: 11032540
    [No Abstract]   [Full Text] [Related]  

  • 16. GPIIb-IIIa receptor inhibitors: what the interventional radiologist needs to know.
    Hofmann LV; Razavi M; Arepally A; Reginelli JP; Resar J; Geschwind JF; Corl F
    Cardiovasc Intervent Radiol; 2001; 24(6):361-7. PubMed ID: 11907740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Furman MI; Krueger LA; Linden MD; Fox ML; Ball SP; Barnard MR; Frelinger AL; Michelson AD
    J Thromb Haemost; 2005 Feb; 3(2):312-20. PubMed ID: 15670038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitors of platelet receptors GP IIB/IIIA: a new therapeutic class and its promise in the treatment of acute coronary syndromes].
    Yerna M; Legrand V; Kulbertus H
    Rev Med Liege; 1997 May; 52(5):329-35. PubMed ID: 9273634
    [No Abstract]   [Full Text] [Related]  

  • 19. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
    Harrington RA
    Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Which, when, how?].
    Juárez Herrera U
    Arch Cardiol Mex; 2001; 71 Suppl 1():S85-90. PubMed ID: 11565353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.